Literature DB >> 29388511

Impaired transport of intrinsically disordered proteins through the Sec61 and SecY translocon; implications for prion diseases.

Sebastian Jung1, Jörg Tatzelt1.   

Abstract

The prion protein (PrP) is composed of two major domains of similar size. The structured C-terminal domain contains three alpha-helical regions and a short two-stranded beta-sheet, while the N-terminal domain is intrinsically disordered. The analysis of PrP mutants with deletions in the C-terminal globular domain provided the first hint that intrinsically disordered domains are inefficiently transported into the endoplasmic reticulum through the Sec61 translocon. Interestingly, C-terminally truncated PrP mutants have been linked to inherited prion disease in humans and are characterized by inefficient ER import and the formation of neurotoxic PrP conformers. In a recent study we found that the Sec61 translocon in eukaryotic cells as well as the SecY translocon in bacteria is inherently deficient in translocating intrinsically disordered proteins. Moreover, our results suggest that translocon-associated components in eukaryotic cells enable the Sec61 complex to transport secretory proteins with extended unstructured domains such as PrP and shadoo.

Entities:  

Keywords:  ER import; Sec61; SecY; intrinsically disordered; neurodegeneration; prion

Mesh:

Substances:

Year:  2018        PMID: 29388511      PMCID: PMC6016518          DOI: 10.1080/19336896.2018.1435936

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  29 in total

1.  Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation.

Authors:  J Ma; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

2.  Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP.

Authors:  Angelika S Rambold; Margit Miesbauer; Doron Rapaport; Till Bartke; Michael Baier; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  Mol Biol Cell       Date:  2006-05-17       Impact factor: 4.138

Review 3.  The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.

Authors:  Konstanze F Winklhofer; Jörg Tatzelt; Christian Haass
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

4.  alpha-Helical domains promote translocation of intrinsically disordered polypeptides into the endoplasmic reticulum.

Authors:  Margit Miesbauer; Natalie V Pfeiffer; Angelika S Rambold; Veronika Müller; Sophia Kiachopoulos; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

5.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.

Authors:  D G Donne; J H Viles; D Groth; I Mehlhorn; T L James; F E Cohen; S B Prusiner; P E Wright; H J Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Wild-type Shadoo proteins convert to amyloid-like forms under native conditions.

Authors:  Nathalie Daude; Vivian Ng; Joel C Watts; Sacha Genovesi; John Paul Glaves; Serene Wohlgemuth; Gerold Schmitt-Ulms; Howard Young; Joanne McLaurin; Paul E Fraser; David Westaway
Journal:  J Neurochem       Date:  2010-01-08       Impact factor: 5.372

7.  Disease-associated prion protein oligomers inhibit the 26S proteasome.

Authors:  Mark Kristiansen; Pelagia Deriziotis; Derek E Dimcheff; Graham S Jackson; Huib Ovaa; Heike Naumann; Anthony R Clarke; Fijs W B van Leeuwen; Victoria Menéndez-Benito; Nico P Dantuma; John L Portis; John Collinge; Sarah J Tabrizi
Journal:  Mol Cell       Date:  2007-04-27       Impact factor: 17.970

Review 8.  Targeting of the prion protein to the cytosol: mechanisms and consequences.

Authors:  Margit Miesbauer; Angelika S Rambold; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  Curr Issues Mol Biol       Date:  2009-09-18       Impact factor: 2.081

9.  Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation.

Authors:  Bettina Drisaldi; Richard S Stewart; Cheryl Adles; Leanne R Stewart; Elena Quaglio; Emiliano Biasini; Luana Fioriti; Roberto Chiesa; David A Harris
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

10.  The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections.

Authors:  Joel C Watts; Bettina Drisaldi; Vivian Ng; Jing Yang; Bob Strome; Patrick Horne; Man-Sun Sy; Larry Yoong; Rebecca Young; Peter Mastrangelo; Catherine Bergeron; Paul E Fraser; George A Carlson; Howard T J Mount; Gerold Schmitt-Ulms; David Westaway
Journal:  EMBO J       Date:  2007-08-16       Impact factor: 11.598

View more
  1 in total

1.  Plastid chaperone HSP90C guides precursor proteins to the SEC translocase for thylakoid transport.

Authors:  Tim Jiang; Bona Mu; Rongmin Zhao
Journal:  J Exp Bot       Date:  2020-12-31       Impact factor: 6.992

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.